Sign in
4

Changes in Ownership

GeneDx Holdings Corp. Filed Acc 0001209191-24-000840

Chief Transformation Officer sold 105 shares at $2.58 ($271)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Saad Kareem Chief Transformation Officer 2024-01-03 Sale −105 $2.58 $271 24,114 D
Open-market sales · 105 sh · avg $2.58 · $271
Loading xslF345X05/doc4.xml…